News

Novo Nordisk ends collaboration with Hims & Hers
Novo Nordisk said it's ending its collaboration due to concerns with Hims & Hers the company's sales and promotion of cheap ...
BioPharma Dive54m
Novo abruptly ends obesity drug deal with Hims
The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...
Finbold3h
Hims & Hers stock crashes over 20% on Wegovy shocker
Hims & Hers Health stock plunged after Novo Nordisk (NYSE: NVO) cut ties over concerns about its handling of Wegovy ...
Forbes12mon
Wegovy Approved In China—But Novo Nordisk Promises Existing Patients Priority Amid Shortages
Ozempic maker Novo Nordisk confirmed Tuesday its popular weight loss drug Wegovy had been approved for sale in China, a key victory for the Danish firm that opens the door to an enormous market ...
Investopedia12mon
Novo Nordisk Rises as Wegovy Is Approved in China
of Danish drugmaker Novo Nordisk rose Tuesday after the company announced that its popular weight-loss drug Wegovy has been approved to start being sold in China. Ozempic, another drug with the ...
Bloomberg L.P.12mon
Novo Nordisk’s Wegovy Approved in China for Weight Loss
China has approved Novo Nordisk A/S’s blockbuster Wegovy for chronic weight management, opening up competition for next-generation obesity drugs in the world’s second-largest economy.
Wall Street Journal12mon
Novo Nordisk’s Wegovy Weight-Loss Drug Gets Approval in China
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk NOVO.B1.91%increase; green up pointing triangle to begin selling it in the world’s second ...
CNN7mon
Weight-loss drug Wegovy launched in China
Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Novo ( NVO ) launched Wegovy in the US ...
Managed Healthcare Executive3h
Novo Nordisk Terminates Collaboration with Hims & Hers
The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded ...
Reuters12mon
Novo Nordisk's Wegovy weight-loss drug approved in China
SHANGHAI, June 25 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world's second-largest economy ...
Zacks Investment Research on MSN5d
Can Ozempic, Wegovy Drive Further Growth for NVO in the Obesity Space?
Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...